RisaMichelleHoffmanMD

Infectious Disease • Los Angeles, CA

HIV/AIDS Medicine

Associate Professor, Medicine, University of California Los Angeles David Geffen School of Medicine

Join to view full profile

Dr. Hoffman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hoffman's full profile

Already have an account?

Office
757 Westwood Plz
Los Angeles, CA 90095
Phone+1 310-206-6766

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 2005 - 2008
Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 2000 - 2005
David Geffen School of Medicine at UCLAClass of 2000

Certifications & Licensure

CA State Medical License 2003 - 2025
MA State Medical License 2003 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV Start of enrollment: 2017 May 31
Terminated
Not Applicable

Publications & Presentations

PubMed

8 citations
Diagnostic Utility and Impact on Clinical Decision Making of Focused Assessment With Sonography for HIV-Associated Tuberculosis in Malawi: A Prospective Cohort Study.
Daniel Kahn, Kara-Lee Pool, Linna Phiri, Florence Chibwana, Kristin Schwab
Global Health, Science and Practice. 2020-03-31
8 citations
Community and health system factors associated with antiretroviral therapy initiation among men and women in Malawi: a mixed methods study exploring gender-specific ba...
Khumbo Phiri, Kaitlyn McBride, Corrina Moucheraud, Misheck Mphande, Kelvin Balakasi
International Health. 2021-04-27
6 citations
Improving ART initiation among men who use HIV self-testing in Malawi: a qualitative study.
Julie A Hubbard, Misheck Mphande, Khumbo Phiri, Kelvin Balakasi, Risa M Hoffman
Journal of the International AIDS Society. 2022-06-01

Press Mentions

Three Steps to Speedier HIV Med Approvals for Pregnant PeopleJune 10th, 2021
Benefits Outweigh Risks of Dolutegravir for Women of Childbearing Age Living with HIV, Study ShowsApril 3rd, 2019
Avoiding Dolutegravir in Young Women with HIV: Time for a Rethink?April 1st, 2019